Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

MDxHealth (MDXH) Income from Continuing Operations (2021 - 2025)

Historic Income from Continuing Operations for MDxHealth (MDXH) over the last 5 years, with Q3 2025 value amounting to -$8.0 million.

  • MDxHealth's Income from Continuing Operations rose 2368.0% to -$8.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$31.1 million, marking a year-over-year increase of 2470.19%. This contributed to the annual value of -$38.1 million for FY2024, which is 1167.29% up from last year.
  • As of Q3 2025, MDxHealth's Income from Continuing Operations stood at -$8.0 million, which was up 2368.0% from -$7.4 million recorded in Q2 2025.
  • MDxHealth's Income from Continuing Operations' 5-year high stood at -$6.7 million during Q4 2024, with a 5-year trough of -$18.1 billion in Q2 2022.
  • Over the past 5 years, MDxHealth's median Income from Continuing Operations value was -$10.0 million (recorded in 2023), while the average stood at -$1.1 billion.
  • As far as peak fluctuations go, MDxHealth's Income from Continuing Operations crashed by 9366.22% in 2022, and later skyrocketed by 9994.13% in 2023.
  • Quarter analysis of 5 years shows MDxHealth's Income from Continuing Operations stood at -$8.1 million in 2021, then tumbled by 50.73% to -$12.2 million in 2022, then rose by 12.02% to -$10.7 million in 2023, then surged by 37.07% to -$6.7 million in 2024, then decreased by 18.93% to -$8.0 million in 2025.
  • Its Income from Continuing Operations was -$8.0 million in Q3 2025, compared to -$7.4 million in Q2 2025 and -$8.9 million in Q1 2025.